0001203311-13-000096.txt : 20131209 0001203311-13-000096.hdr.sgml : 20131209 20131209183804 ACCESSION NUMBER: 0001203311-13-000096 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20131205 FILED AS OF DATE: 20131209 DATE AS OF CHANGE: 20131209 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: SEATTLE GENETICS INC /WA CENTRAL INDEX KEY: 0001060736 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 911874389 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4255274000 MAIL ADDRESS: STREET 1: 21823 30TH DRIVE SE STREET 2: SUITE CITY: BOTHELL STATE: WA ZIP: 98021 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SIEGALL CLAY B CENTRAL INDEX KEY: 0001167496 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-32405 FILM NUMBER: 131266648 MAIL ADDRESS: STREET 1: 21823 30TH DR SE CITY: BOTHELL STATE: WA ZIP: 98021 4 1 edgardoc.xml PRIMARY DOCUMENT X0306 4 2013-12-05 0 0001060736 SEATTLE GENETICS INC /WA SGEN 0001167496 SIEGALL CLAY B 21823 30TH DRIVE SE BOTHELL WA 98021 1 1 0 0 President and CEO Common Stock 2013-12-05 4 M 0 18996.0 5.92 A 1043554 D Incentive Stock Option (right to buy) 5.92 2013-12-05 4 M 0 18996.0 0.0 D 2006-01-31 2015-01-31 Common Stock 18996 0 D Amount of securities beneficially owned following reported transactions includes 189,250 Restricted Stock Units subject to vesting. 25% of the shares vested on 1/31/06. The remainder vested monthly thereafter until all shares were vested on 1/31/09. Clay B. Siegall 2013-12-09